- •Rituximab has been frequently utilized for the treatment of a wide range of neurologic diseases including 'Devic's syndrome.
- •Previous case reports have described cases of osteonecrosis, retinal and nasal skin necrosis.
- •This case report addresses a patient with 'Devic's syndrome presented with palatal mucosal necrosis after rituximab treatment.
- •Due to the increasing administration of rituximab, awareness about mucosal necrosis should be raised.
2. Case report
Declaration of Competing Interest
- Association of osteonecrosis of the jaws and poems syndrome in a patient assuming rituximab.J. Cranio-Maxillo-Facial Surg. 2014; 42: 279-282
- Rituximab in the treatment of neuromyelitis optica: a multicentre Italian observational study.J. Neurol. 2016; 263: 1727-1735
- Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study.J. Neurol. 2018; 265: 917-925
- Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis.JAMA Neurol. 2016; 73: 1342-1348
- Progressive outer retinal necrosis after rituximab and cyclophosphamide therapy.Indian J. Ophthalmol. 2018; 66: 591-593
- Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.J. Intern. Med. 2005; 257: 540-548
- Azathioprine induced pancytopenia: a serious complication.J. Postgrad. Med. 2009; 55: 139-140
- Effectiveness of rituximab for the treatment of rheumatoid arthritis in patients with prior exposure to anti-TNF: results from the CORRONA registry.J. Rheumatol. 2015; 42: 1090-1098
- Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature.Nephrol. Dial. Transplant. 2015; 30: 91-96
- Rituximab-induced serum sickness: a systematic review.Semin. Arthritis Rheum. 2015; 45: 334-340
- Osteonecrosis of the jaw in a patient presenting with post-transplantation lymphoproliferative disorder treated with rituximab: a case report.J. Oral Maxillofacial Surg. 2017; 75: 2599-2605
- Diagnostic features of common oral ulcerative lesions: an updated decision tree.Int. J. Dent. 2016; 20167278925
- Development of nasal skin necrosis associated with rituximab treatment for Waldenstrom’s macroglobulinemia and subsequent spontaneous resolution.Ear Nose Throat J. 2016; 85: 431-433
Ramesh Amirisetty, V.Z., Meenakshi Boddun, Rolly Gupta, Micky Kumari, Hema Suryawanshi. 2006. Treatment emergent agranulocytosis with skin and gingival lesions in a chronic lymphocytic leukemia patient: a case report. 10(10):ZD13–ZD6.
- Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.Annu. Rev. Med. 2004; 55: 477-503
- Azathioprine-induced agranulocytosis and severe alopecia after kidney transplantation associated with a NUDT15 polymorphism: a case report.Transplant. Proc. 2018; 50: 3925-3927
- Adverse reactions of antibody-therapy for primary cutaneous lymphomas: rituximab, brentuximab vedotin, alemtuzumab, and mogamulizumab.Curr. Probl. Dermatol. 2018; 53: 70-81
- Rituximab and acute retinal necrosis in a patient with scleromalacia and rheumatoid arthritis.Ocul. Immunol. Inflamm. 2016; 24: 96-98
- Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren’s syndrome.Ann. Rheum. Dis. 2007; 66: 351-357
- Rituximab versus cyclophosphamide for ANCA-associated vasculitis.N. Engl. J. Med. 2010; 363: 221-232
- Efficacy and safety of rituximab in systemic sclerosis: french retrospective study and literature review.Autoimmun. Rev. 2018; 17: 582-587